Current Data Requests

The Maine Health Data Organization has, in accordance with Rule Chapter 120: Release of Data to the Public, instituted a process for the purpose of notifying users and providers of health care data when the MHDO receives a request for health data and accepts that request. In addition to sending electronic notification to interested parties and to providers that are responsible for the submission of the data, we provide the summary page of data requests below.

For all data requests, the data providers or other interested parties may submit comments related to the data request to the Executive Director. To be considered, comments must be received by the Executive Director in writing or by electronic notification no later than thirty business days after the initial posting of the data request on the MHDO web site. If the Executive Director determines that (a.) the comments received are of significant enough importance to delay the release of data and/or (b.) additional information is required from the requesting party to address the comments; then the data shall not be released until the additional information has been received from the requesting party and an additional review is conducted by the Executive Director or the MHDO Data Release Subcommittee, as applicable, to ensure that the requesting party conforms to all applicable requirements of this chapter.

The Executive Director will bring all comments received from the data providers and or other interested parties for the release of Level III Data to the MHDO Data Release Subcommittee for consideration.

Individuals who want to opt out of a specific Level III data request may do so by completing this MHDO Choice Disclosure Form no later than 30 business days after the initial posting of the data request. If you opt out of Level III data requests, you will remain opted out unless you choose to opt back in via completion of the MHDO Choice Disclosure Form.

NOTE: If you would like to be notified when new data requests are posted, please email your request.

12345678910...>>
Request NumberRequesting PartyAffiliationDate Posted Comment Close DateSpecific Data RequestPurpose of Request/Benefits to the Citizens of Maine/Public Reporting PlansReleased/Denied
2022062905Jonk, Yvonne, Asst. Research Prof.University of Southern Maine9-29-202211-14-2022Level II Q1 2021 - Q4 2021 Medical Claims and Medical Eligibility data released at the County and Age level.Level II Data Request: USM was previously authorized under Data Request #2020081102 to utilize the requested MHDO APCD dataset for Q1 2012 - Q4 2020. This data request is an extension of that project, whereby researchers at USM have been conducting a multi-payer study of trends in telehealth use by children in Maine. The study uses Maine's All-Payer Claims Database (APCD) to develop a descriptive overview of telehealth use in Maine, examining how telehealth use has changed over time among rural and urban children and whether there are discernable patterns in those changes by telehealth modality, payer, provider type, diagnosis and service. USM has been documenting the potential need for expanded use of telehealth services among rural pre-school and school aged children within the state of Maine. USM is seeking authorization to use this dataset for the continuation of the telehealth research project described above. Benefit to Citizens of Maine: This project will benefit the people of Maine by informing and facilitating the development of targeted telehealth training programs that will help fill gaps in telehealth workforce shortages throughout the state and improve access to health services by expanding telehealth workforce capacity. 
2022083101Ahrens, Katherine, Asst. Research Prof.University of Southern Maine9-21-202211-3-2022Level II Q4 2015 - Q1 2020 Hospital Inpatient and Outpatient Encounter data released by City/Zip and DOB, including breakdown by Race/Ethnicity.Level II Data Request: Respiratory tract infections are a leading cause of hospitalization and emergency department visits among infants in the United States. Infants who receive childcare at home are less likely to contract a respiratory tract infection than those who receive out-of-home childcare, but it is unknown whether provision of paid parental leave reduces emergency department visits and hospitalizations related to respiratory tract infections. Further, it is unknown if any beneficial effects of paid family leave on respiratory tract infection are experienced equitably across race/ethnicity and socio-economic groups. This data will be used as part of a National Institute of Health (NIH)-funded project to look at the effect of New York State's paid family leave policy, enacted January 1, 2018. The research aims to determine the effect the policy may have on: 1) Reduced rates of acute care encounters for respiratory tract infections and 2) Reduced disparities in rates of acute care encounters for respiratory tract infections by neighborhood socio-economic status or racial-ethnic group. Data from Maine, Vermont, New Hampshire, and Massachusetts will act as controls, currently having no paid family leave policy in place. Benefit to Citizens of Maine: Our project will benefit the people of Maine because it will evaluate the effect of paid family leave on infant health; this is a timely and relevant evaluation, as Maine policy-makers are considering introducing paid family leave in our state. Our primary anticipated audience is the scientific community and policy-makers interested in implementing paid family leave. We anticipate submitting our findings for publication in the peer-reviewed literature. 
2022060710King, Nicholas, Sr. Decision Support AnalystMaineGeneral8-26-202210-11-2022Level II Q1 2022 - Q4 2022 Medical Claims, Medical Eligibility, Pharmacy Claims, Pharmacy Eligibility, Dental Claims, Dental Eligibility, Hospital Inpatient and Outpatient Encounter data including Practitioner Identifiers released at the City/Zip and Age level.Level II Data Request: As the third largest healthcare system in the state, MaineGeneral Health is entrusted with the responsibilities of both safeguarding the health of residents in 86 communities in central Maine, and for providing them with the healthcare services they need. Decisions on optimal allocation of our resources to best serve this population can be informed by access to MHDO data leading to improved care for those communities. This data would enable us in achieving our goals of improving health and wellbeing, enhancing treatment outcomes, offering timely access to quality care, and providing seamless care coordination to those within the state we serve. It would also enable reporting of market share data with our member organizations or prospective affiliates with the goal of improving care for all Maine residents. Data will also assist us in supporting member organizations taking on the responsibilities and risks of Accountable Care Organizations and Medicare Share Savings Program participation, as well as commercial payer contracts. Supporting MaineGeneral Health and its members' Certificate of Need applications, and Maine Shared Community Health Needs Assessment, as well as strategic and service line work medical staff development, and facility planning are all additional important uses of this data which ultimately allow us to provide excellent care to the residents of Maine. Benefit to Citizens of Maine: Specifically, MHDO data will be used to affect improvements in the quality and safety of our services and identify cost-saving opportunities, providing tangible benefits to the people of Maine. 
2022061601Jonk, Yvonne, Associate Research ProfessorUniversity of Southern Maine7-26-20229-7-2022Level II Q1 2018 – Q4 2021 Medical Claims, Medical Eligibility, Pharmacy Claims, Pharmacy Eligibility data released at the CityZip and Date of Birth level. Also includes Practitioner Identifiable data.Level II Data Request The COVID-19 pandemic has created unprecedented challenges for the healthcare and public health systems. Healthcare providers have had to grapple with sudden changes in care delivery, ranging from potential inpatient bed capacity constraints, to delays in care for regular patients, to the need to remotely manage medically and socially complex patients. Public health agencies have had to quickly ramp up testing and then vaccine delivery at an unprecedent scale. A particular challenge has been to provide Covid-19 testing and treatment for already disadvantaged and vulnerable populations. This study will identify social, behavioral, structural and policy factors that are sources of COVID-19 disparities among rural populations, with the goal of addressing and decreasing COVID-19 testing inequalities in Maine. 
2022062903Matusovich, Becca, Executive DirectorPartnership for Children’s Oral Health7-26-20229-7-2022Level II Q1 2016 – Q2 2022 Medical Claims, Medical Eligibility, Dental Claims, Dental Eligibility data released at the City/Zip and Date of Birth level. Also includes Practitioner Identifiable data.Level II Data Request: The Partnership for Children’s Oral Health is a broad network of oral health stakeholders who are collaborating toward a shared mission: eradicating dental disease among Maine children. A key piece of this work is to strengthen the capacity of Maine’s oral health service delivery systems to reach all children in Maine with effective preventive and restorative dental care. In order to create a shared understanding of the strengths and challenges of the current delivery system. This analysis builds off of previous analyses using MHDO’s all-payer claims data that will provide a snapshot of current patterns in utilization of preventive and restorative dental services and look at variations in utilization and cost across payer/insurer type, age group, location/geography, provider type, and setting of care. Additionally, summary data will be reported on children's dental health use to the Kids Count Project. This project will benefit the people of Maine because it will help to build shared understanding of ways in which the current delivery system is able to meet the needs of Maine children, and what gaps remain. This will allow for collaborative planning to align resources and coordinate efforts to fill the gaps and increase children’s access to recommended oral health care. 
2021092901Moores, Emily, Senior Health Program ManagerMaine DHHS-CDC7-26-20229-7-2022Level II Q1 2016 – Q4 2021 Medical Claims, Medical Eligibility data released at the City/Zip and Date of Birth level. Also includes Practitioner Identifiable data.Maine CDC is requesting a custom extract of aggregated claims with the principal diagnoses related to Alzheimer’s Disease and Related Dementia (ADRD). We are requesting the extract include the following dimensions: year, age group, gender, race/ethnicity, payer type, reason for visit, and county. This data will be utilized to change systems, environments, and policies in Maine to promote risk reduction, to improve early diagnosis, to prevent and manage comorbidities, and to avoid hospitalizations related to ADRD. ME CDC will use the data to set priorities, to develop public health actions, to address social determinants of health, and to provide support for caregivers who take care of people with dementias. ME CDC has been awarded grant to fund this work all aimed at preventing ADRD and increasing early detection and intervention and improve supports for families coping with ADRD – all of which will improve outcomes for the citizens of Maine who are diagnosed with ADRD and their families. 
2022060713Ahrens, Katherine, Asst. Research ProfessorUniversity of Southern Maine7-25-20229-6-2022Level II Q1 2006 - Q4 2022 Medical Claims, Medical Eligibility, Pharmacy Claims, Pharmacy Eligibility data released at the City/Zip and DOB level .Level II Data Request: The purpose of this project is to assess maternal health care utilization and morbidity in the first 24 months' postpartum among women in Maine during 2006-2022, focusing on women with medical conditions commonly diagnosed during pregnancy. We will assess if rural versus urban residence modifies postpartum health care utilization and morbidity, and how delayed contraception initiation affects short interpregnancy intervals. The findings from our analysis may be used to decrease the risk of future adverse health outcomes for women with common pregnancy conditions, thereby contributing to lowering maternal morbidity and mortality in the US. Benefit to Citizens of Maine: This project will benefit the people of Maine by identifying opportunities for healthcare interventions postpartum to improve reproductive women's health. 
2022061001Raymond, Ruby, Dir. of DevelopmentMaine Cancer Foundation6-17-20228-2-2022Level II Q1 2015 - Q4 2022 Medical Claims, Medical Eligibility, Pharmacy Claims, Pharmacy Eligibility, Hospital Inpatient and Hospital Outpatient data released at the City/Zip and Date of Birth level and with Practitioner Identifiers.Level II Data Request: The purpose of this project is to create Maine's first comprehensive Cancer Blueprint, to increase knowledge and awareness of issues related to cancer, expand access to care, and support lifestyle changes to reduce cancer risk by exploring inequities and variations in cancer rates, by examining factors that may influence cancer risk, and analyzing how factors such as social determinants of health, race, ethnicity, insurance status, and socio-economic status influence health outcomes. Under contract with the Human Services Research Institute (HSRI), the Maine Cancer Foundation (MCF) plans to use the MHDO data to assist in identifying variations in cancer incidence, mortality, cost, screening rates, and access to care across Maine. The MHDO dataset may also be used in the development of ad hoc reporting requests directed by an advisory group formed by the MCF and comprised of clinical and other public health experts. Benefit to Citizens of Maine: The information developed for the Blueprint will be publicly available to Maine clinical experts, residents and others who are interested in actionable statistics related to cancer in Maine. 
2022041201Linehan, Patrick, Production AssociateABC New6-6-20227-19-2022Ad Hoc Request - 2018, 2019, 2020 & 2021 ECT Treatments identified in MHDO Claims Data.To be used in a news story about the use of ECT treatments in the country. ABC news is looking into the use of Electroconvulsive therapy throughout the United States and want to understand how often the procedure is used and how much money was spent on it in the state of Maine over the past 4 years. Benefit to Citizens of Maine: The MHDO data will help us understand how frequently the procedure is conducted in Maine. Because the procedure is controversial, the people of Maine should know how frequently it is practiced in their state. 
2021121401Weiss, Diane, Dir. Business IntelligenceInterMed, P.A.6-3-20227-19-2022Level II Q3 2021 - Q2 2022 Medical Claims and Medical Eligibility at the City/Zip and Age level including Practitioner Identifiers.Level II Data Request: InterMed is requesting an additional year of the most current MHDO claims data that will be used to continue their work specific to identifying opportunities to improve access, quality, and cost of care. Analyses include identifying where patients are driving long distances to receive regular care for chronic conditions like diabetes. Identify potential locations to expand services including community based ambulatory care, partnerships with employers and regional health systems that will improve access. InterMed also plans on using claims data to better understand the uptake of telehealth and opportunities to enhance those services and potentially integrate remote monitoring for hard to control conditions like hypertension. InterMed will use MHDO data to develop strategies to address clinical and social determinants of health. For example, using diagnosis to risk stratify populations and inform personalized healthcare services like care coordinators and dietitians for the highest risk populations. Benefit to Citizens of Maine: InterMed's use of the MHDO data will directly impact quality and operational improvement activities in our organization and thus benefit our patients. This data will help inform our decisions regarding the allocation of primary care and specialty services and enable us to develop targeted new programs. 
2022050601Lincoln, Rebecca, EPHT Prog. CoordinatorMaine CDC Enviro. Public Health Tracking Prog.5-9-20226-21-2022Ad-Hoc report for the Maine CDC for an analysis of carbon monoxide (CO) poisoning. MHDO data sources are Level II CY 2018 and 2019 Hospital Inpatient and Outpatient encounters.Level II Data Request: Under the 'Rules for Control of Notifiable Conditions', mandated reporters, including healthcare providers, medical laboratories, and healthcare facilities must report all cases of carbon monoxide (CO) poisoning to the Maine CDC within 48 hours. In keeping with this mandate, Maine CDC's Environmental Public Health Tracking (EPHT) Program routinely utilizes MHDO administrative data to identify records with billing codes related to CO poisoning that have not been previously reported. With this information, the Maine CDC can continue to develop focused strategies for the prevention of CO poisoning of Maine residents. 
2019062504Harrington, Karynlee, DirectorMaine Quality Forum4-19-20226-1-2022Level II Q1 2016 - Q4 2021 Medical Claims, Medical Eligibility, Pharmacy Claims, Pharmacy Eligibility released at the City/Zip and Date of Birth level including Practitioner Identifiers, Payer Group ID, Payer Name/ID and Anonymous Payer Name/ID; and non-claims based payments, including supplemental data sets defined in Public Law 2022, Chapter 603.Level II Data Request: Both Public Law 244, An Act to Establish Transparency in Primary Care Spending; and Public Law 2022, An Act Regarding Reporting on Behavioral Health Care Services and to Clarify the Requirements for Credentialing by Health Insurance Carriers, requires the Maine Quality Forum (MQF) to produce an annual spending report for primary care and behavioral health care services in Maine using data from the Maine Health Data Organization. The report will include the percentage paid (claims and non-claims payments) as a percentage of the respective total medical expenditures for primary care and behavioral health care by commercial insurers, the MaineCare program, Medicare, and the State Employee Plan and the Maine Education Association Benefits Trust; as well as the average percentage of total medical expenditures paid for primary care and behavioral health care across all payors. The reports will be submitted in January 2023 to the Commissioner of the Department of Health and Human Services and the joint standing committee of the Legislature having jurisdiction over health coverage and health insurance matters. 
2022020201Nelson, Sheila, Program Manager, Adolescent HealthDHHS, Maine CDC3-14-20224-26-2022Level II Q1 2016 - Q4 2020 Medical Claims released at the member City/Zip, and Date of Birth level.Level II Data Request: The purpose of this study is to use MHDO's all-payer claims data to explore claims related to suicide attempts and suicide ideation. Specifically, the Maine CDC's Adolescent Health and Injury Prevention Program in collaboration with the University of Southern Maine's Muskie School of Public Health is interested in examining health care utilization patterns prior to and after an emergency department visit and/or hospitalization for a suicide attempt. Results from these analyses will allow the Maine CDC to identify opportunities for primary prevention and better understand follow-up care received following a suicide attempt. Benefit to Citizens of Maine: Results from these analyses will be used to train and health care providers about care around a suicide attempt. This will ensure better care for those at-risk for self-harm and may reduce Maine's suicide morbidity and mortality rates. 
2021112301Bradshaw, Jay, Executive DirectorMaine Ambulance Association3-14-20224-26-2022Level II Q1 2019 - Q3 2021 Medical Claim Data including Practitioner Identifiers.Level II Data Request: MHDO's claims data will be used to analyze ambulance services provided in Maine, including revenue sources and access. The analysis of revenue streams from all payors will be used to examine opportunities to improve financial support for EMS services across the State. Benefit to Citizens of Maine: improvements to the services EMS providers deliver to Maine citizens, including improved quality and access. 
2022020401Harakall, Maryann, Maternal and Child Health Dir.DHHS, Maine CDC3-10-20224-22-2022Level II Q1 2016 - Q1 2022 Hospital Inpatient data released at the Member City/Zip and Date of Birth level.Level II Data Request: In 2021 Maine received funds to become part of the National Alliance for Innovation on Maternal Health (AIM). This initiative involves engaging hospitals in the implementation of patient safety bundles designed to improve the quality of health care provided to women around the time of pregnancy. The goal of the AIM initiative is to reduce maternal mortality and morbidity. Maine selected to focus on maternal hypertension as the state's first QI initiative. The Maine CDC will use the MHDO's hospital data to conduct these analyses; the MHDO data will also support ongoing monitoring of maternal morbidity to assess the effectiveness of the implementation of these evidence-based practices in Maine hospitals. Benefit to Citizens of Maine: Maine people will benefit from a data-driven approach to implementing best practices related to reducing maternal morbidity. 
2021091501Taylor, Patrick, Dr., MD, MBA, Pres and CEOYork Hospital1-28-20223-14-2022Level II Q1 2017 - Q3 2021 Hospital Inpatient and Outpatient Encounters including Practitioner Identifiers released at the Age and County Level.Level II Data Request: York Hospital will use MHDO data to keep abreast of the evolving healthcare landscape around services needed and resource allocations especially to better understand the impact of the COVID 19 pandemic and its impact on the health needs of our patient population. MHDO data will also be used to appropriately optimize resource allocations. Zip code level data will allow York Hospital to understand important care delivery factors like distances traveled by patients to receive services. Provider identification data will inform decision-making regarding future placement of services and providers and/or collaborative efforts to improve access to health care services. MHDO data will also allow York Hospital to strategically plan for the needs of non-COVID patients. Benefit to Citizens of Maine: York Hospital will conduct these analyses and others as needed to support individual projects and help provide a strategic framework with the ultimate goal of providing the people of Maine with the right care of the highest quality, at the right time, in the right place. 
2017081603Chawla, Chiahui, Bur. Chief, PH Statistics and InformaticsNH DHHS12-10-20213-22-2022Level II Q1 - Q4 2022 Hospital Inpatient and Outpatient Encounter data released at the City/Zip and DOB level. Level II Data Request: This request is a modification of a previously approved request to include the following additional year of data - CY2022. On-going surveillance of hospital encounters plays in important role in understanding and reacting to disease and injury. NH Division of Public Health Services (NH DPHS) has several programs that address acute disease, chronic disease, and injury. NH DPHS is the lead agency responsible for detecting and responding to health emergencies such as infection disease outbreaks and exposures to health hazards. Discharge and outpatient visits data on NH residents from hospitals in Maine are important, especially for border towns. Without out-of-state hospital data, public health analysis will not be reliable. This request is to obtain hospital encounters for both inpatient and outpatient on NH residents treated in hospitals in Maine. The purpose for the collection of such data is to assess the health of the citizens of NH, to identify specific health threats in NH, to support research into the cause of disease or injury, and to generally improve the public health of the State. NH state laws also provide for the protection of the confidentiality of information and data relative to specific individuals, while assuring appropriate accessibility of this data for legitimate public health activities. To accomplish its statutory mission, DPHS must analyze selected data from MHDO. Several NH DPHS programs have collaboration projects with state/local agencies or programs in Maine. For example, the NH Environmental Public Health Tracking (NH EPHT) Program has been working with ME Environmental Public Health Tracking (ME EPHT) Program for years on climate change, heat stress, Lyme disease and social vulnerability index projects using hospital discharge and outpatient encounter data. Benefit to Citizens of Maine: Because of the data sharing and collaboration, people of ME are benefiting from the project results in terms of determining vulnerable areas and impacts on public health. 
2021061501King, Nicholas,Senior Decision Support AnalystMaine General11-24-20211-11-2022Level II Q1 2021 - Q4 2021 Medical Claims, Medical Eligibility, Pharmacy Claims, Pharmacy Eligibility, Dental Claims, Dental Eligibility, Hospital Inpatient and Outpatient Encounter data including Practitioner Identifiers released at the City/Zip and Age level.Level II Data Request: As the third largest healthcare system in the state, MaineGeneral Health is entrusted with the responsibilities of both safeguarding the health of residents in 86 communities in central Maine, and for providing them with the healthcare services they need. Decisions on optimal allocation of our resources to best serve this population can be informed by access to MHDO data leading to improved care for those communities. This data would enable us in achieving our goals of improving health and wellbeing, enhancing treatment outcomes, offering timely access to quality care, and providing seamless care coordination to those within the state we serve. It would also enable reporting of market share data with our member organizations or prospective affiliates with the goal of improving care for all Maine residents. Data will also assist us in supporting member organizations taking on the responsibilities and risks of Accountable Care Organizations and Medicare Share Savings Program participation, as well as commercial payer contracts. Supporting MaineGeneral Health and its members' Certificate of Need applications, and Maine Shared Community Health Needs Assessment, as well as strategic and service line work medical staff development, and facility planning are all additional important uses of this data which ultimately allow us to provide excellent care to the residents of Maine. Benefit to Citizens of Maine: Specifically, MHDO data will be used to affect improvements in the quality and safety of our services and identify cost-saving opportunities, providing tangible benefits to the people of Maine. 
2021020301Merchant, Gary, RepresentativeNew Hampshire House of Representatives11-19-20211-6-2022The names of the pharmaceutical entities registered in the MHDO Prescription Drug Price Data Portal and company information limited to entity type (manufacturer, wholesale distributor or pharmacy benefits manager), federal tax ID, address, city, state, zip code and country.Data Request: The New Hampshire Prescription Drug Affordability Board requests the following information to understand the landscape of pharmaceutical entities that may manufacture products distributed in new Hampshire and other states. This information will assist the board to meet its' statutory obligations and requirements outlined in New Hampshire RSA 126-BB. Benefit to Citizens of Maine: N/A 
2021020303York, Andrew, Pharm.D., J.D. Executive DirectorMaryland Prescription Drug Affordability Board11-19-20211-6-2022The names of the pharmaceutical entities registered in the MHDO Prescription Drug Price Data Portal and company information limited to entity type (manufacturer, wholesale distributor or pharmacy benefits manager), federal tax ID, address, city, state, zip code and country.Maryland requests the following information to understand the landscape of pharmaceutical entities that may manufacture products that are distributed in Maryland and other states. This information will help the Maryland Prescription Drug Affordability Board on their work to catalogue and collect data on manufacturers in the drug supply chain. Benefit to Citizens of Maine: N/A 
2021101301Jorgeson, David, Dir. of Data AnalyticsME Dept. of Health & Human Services, MaineCare11-10-202112-28-2021Level II Q3 2020 - Q2 2021 Medical Claims, Medical Eligibility, Dental Claims, Dental Eligibility including Group Name and Payer Name/ID released at the County and Age level.Level II Data Request: MaineCare's Comprehensive Rate System Evaluation recommended that MaineCare establish rate benchmarks from commercial payers for dental services to establish MaineCare's rates of reimbursement for those services. MHDO's data will be used to establish those benchmarks. Many of MaineCare's dental rates have not been updated in many years, and many rates do not have a clear, consistent methodology documented for creating the rate. Rationalizing MaineCare rates and using consistent benchmarks will result in improved rates. Benefit to Citizens of Maine: This project is intended to improve reimbursement for MaineCare dental providers and increase access to dental services for MaineCare members. Public Reporting Plans: MaineCare will update Section 25 of its dental fee schedule with the benchmarks calculated from the MHDO data provided. The updates to the fee schedule will be the updated MaineCare reimbursement rates set off of the commercial benchmarks. No MHDO data will be included in the fee schedule, but the commercial median rates in MHDO's data could be determined from the fee schedule rates. MaineCare will also update Table 5 that was included in MaineCare's Comprehensive Rate System Evaluation Interim Report. 
2021101801Taylor, Rebecca, Deputy Dir. Research and EvaluationMaine DHHS, Office of Behavioral Health10-27-202112-13-2021Level II Q1 2016 - Q1 2021 Medical Claims, Medical Eligibility, Pharmacy Claims, Pharmacy Eligibility, Hospital Inpatient and Outpatient Encounters data released at the City/Zip and DOB level including Practitioner Identifiers.Level II Data Request: The purpose of this project is to investigate and quantify the impact of COVID-19 pandemic restrictions have had on access to and utilization of behavioral health care services in Maine. The Office of Behavioral Health (OBH), a division of the Maine Department of Health and Human Services (DHHS), is the state authority responsible for ensuring timely access to quality behavioral health care for Maine residents. As part of this mandate, OBH engages in research to identify trends in behavioral health service utilization to inform state resource planning and policy development. This particular project will inform allocation of COVID-19 relief grant funding from the federal government directed towards mitigating the behavioral health impact that the pandemic has had on residents of Maine. Benefit to Citizens of Maine: The direct benefit to Mainers will be evidence-based policy and resource allocation decision making that will direct help to those communities and individuals who have been the most adversely affected by the COVID-19 pandemic. 
2019100804Mellett, Jean, Associate VP, Planning & StrategyNorthern Light Health10-27-202112-13-2021Level II CY 2021 - CY 2022 Hospital Inpatient and Outpatient Encounters including Practitioner Identifiers and City/Zip data elements.Level II Data Request: MHDO data will be used to appropriately optimize resource allocations. Zip code level data will allow planners to understand important care delivery factors like distances traveled by patients to receive services. Provider identification data will inform decision-making regarding future placement of services and/or collaborative efforts to improve access to health care services. Additionally, MHDO data will be used to better understand the impact of the COVID 19 Pandemic; specifically, how resources are used and allocated to provide proper care to patients with this illness, while simultaneously meeting the needs of non-COVID patients. Benefit to Citizens of Maine: MHDO data will allow planners to keep abreast of the pandemic's effect on healthcare patterns. Northern Light Health planning staff will conduct these analyses and others as needed to support individual projects and help provide a strategic framework with the ultimate goal of providing the people of Maine with the right care, at the right time, in the right place. 
2021081201Weiss, Diane, Director, Business IntelligenceInterMed, P.A.10-21-202112-7-2021Level II Q3 2020 - Q2 2021 Medical Claims data released at the City/Zip and Age level including Practitioner Identifiers.Level II Request: InterMed plans on using MHDO's claims data to identify opportunities to improve access, quality, and cost of care. For example, analysis will include identifying where patients are driving long distances to receive regular care for chronic conditions like diabetes. Identify potential locations to expand services including community based ambulatory care, partnerships with employers and regional health systems that will improve access. InterMed also plans on using claims data to better understand the uptake of telehealth and opportunities to enhance those services and potentially integrate remote monitoring for hard to control conditions like hypertension. InterMed will use MHDO data to develop strategies to address clinical and social determinants of health. For example, using diagnosis to risk stratify populations and inform personalized healthcare services like care coordinators and dietitians for the highest risk populations. Benefit to Citizens of Maine: InterMed's use of the MHDO data will directly impact quality and operational improvement activities in our organization and thus benefit our patients. This data will help inform our decisions regarding the allocation of primary care and specialty services and enable us to develop targeted new programs. 
2021080901Ahrens, Katherine, Assistant Research Prof.University of Southern Maine10-1-202111-6-2021Level II CY 2009 - CY 2021 Hospital Inpatient Encounter data released at the City/Zip, Date of Birth level.Level II Data Request: A team from the USM Health Data Analytics Research Cluster at USM will analyze the Maine state-specific hospital inpatient discharge data available through the Maine Health Data Organization to explore characteristics and trends in hospitalizations in Maine affected by substance use disorder from 2009 through 2021. The specific research questions are: 1. What are the trends in substance use-related delivery and newborn hospitalizations in the state of Maine? 2. Do these trends vary by level of rurality of patient's residence or other patient characteristics? 3. What are the co-morbidities associated with substance use-related delivery and newborn hospitalizations in Maine? The team will estimate the trends and characteristics that make up substance use-related delivery and newborn hospitalizations in the state of Maine. This information can lead to the development of interventions to prevent these types of hospitalizations, thereby benefitting the people of Maine. Benefit to Citizens of Maine: This information can lead to the development of interventions to prevent these types of hospitlizations, thereby benefitting the people of Maine. 
12345678910...>>